What insurance policy changes affect code M19.041?

There are 3 tracked policy changes affecting code M19.041, including updates from Aetna. Each change may modify coverage criteria, reimbursement rates, or prior-authorization requirements.

Which payers have updated policy for code M19.041?

Payers that have issued tracked updates for code M19.041 include: Aetna.

How do I get notified when code M19.041 policy changes?

Create a free account at PolicyChanges.app and save a search filtered to code M19.041. You will get an email when new policy changes reference this code: daily or weekly, your choice, on every plan.

Why do payers change policies for code M19.041?

Payers revise policies for individual billing codes to align with updated clinical guidelines, CMS rule changes, fraud and abuse prevention measures, or network cost-management goals. Changes can affect medical necessity criteria, place-of-service restrictions, bundling rules, or whether a code requires prior authorization.

PAYER POLICY CHANGES

M19.041 Insurance Policy Changes

ICD-10 M19.041 is officially defined as "Primary osteoarthritis, right hand." code M19.041 is referenced in 3 tracked payer policy changes from Aetna. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for code M19.041 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Aetna · Identified Aug 19, 2026Medium impact
Wrist Arthroplasty (CPB 0853, reviewed 2026-02-25)
Historical (last reviewed 02/25/2026): Aetna considers total wrist arthroplasty medically necessary only for rheumatoid arthritis affecting the wrist, in persons with radiographic evidence of wrist joint destruction and demonstrated resistance or failure to conservative medical treatment of at least 3 months with NSAIDs, DMARDs, and/or glucocorticoids, as appropriate. Total wrist arthroplasty is considered experimental, investigational, or unproven for other diagnoses, including comminuted distal radius fracture, Kienbock's disease, osteoarthritis, post-traumatic arthritis, scaphoid non-union, and scapholunate dissociation. Wrist hemiarthroplasty, selective or complete wrist denervation, the Integra Freedom implant, the Prosthelast, the Universal 2 system, and the Motec and ReMotion prostheses for non-rheumatoid wrist arthritis are also considered experimental, investigational, or unproven.
Aetna · Identified Aug 14, 2026Medium impact
Distal Interphalangeal (DIP), Metacarpophalangeal (MCP) and Proximal Interphalangeal (PIP) Joint Implants (CPB 0798, reviewed 2026-02-24)
Aetna considers MCP and PIP joint implants medically necessary for members with symptomatic rheumatoid arthritis, systemic lupus erythematosus, osteoarthritis, or post-traumatic arthritis when conservative medical management fails to relieve pain or digit deformity interferes with hand function and activities of daily living. The listed implants are Ascension MCP and Integra PyroCarbon MCP implants when soft tissue reconstruction can provide adequate stabilization, Ascension PIP and Avanta MCP and PIP implants when soft tissue and bone can provide adequate stabilization and fixation, and silicone-elastomer MCP and PIP total joint implants. Aetna considers the other MCP and PIP implant indications, DIP joint implants and splints, CMC and TMC joint implants, CapFlex-PIP, Tactys, Silktoe, PIP resurfacing arthroplasty, and X-Fuse for DIP joint arthrodesis experimental, investigational, or unproven.
Aetna · Identified Nov 2, 2026Low impact
Distal Interphalangeal (DIP), Metacarpophalangeal (MCP) and Proximal Interphalangeal (PIP) Joint Implants (CPB 0798, reviewed 2026-10-30)
Aetna reviewed its clinical policy bulletin on finger and thumb joint implants (CPB 0798) on 10/30/2026. The bulletin says Aetna covers certain MCP and PIP joint implants for symptomatic rheumatoid arthritis, lupus, osteoarthritis or post-traumatic arthritis when conservative care has failed, and it calls DIP, CMC/TMC, CapFlex-PIP, Tactys, X-Fuse, Duafit, Silktoe and PIP resurfacing implants experimental, investigational or unproven. The source does not say what changed from the prior version and gives no new effective date.

Watch M19.041

Get one email when a payer policy names M19.041, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.

Create a free alert How Policy Monitoring works

Wrist Arthroplasty (CPB 0853, reviewed 2026-02-25)

Distal Interphalangeal (DIP), Metacarpophalangeal (MCP) and Proximal Interphalangeal (PIP) Joint Implants (CPB 0798, reviewed 2026-02-24)

Distal Interphalangeal (DIP), Metacarpophalangeal (MCP) and Proximal Interphalangeal (PIP) Joint Implants (CPB 0798, reviewed 2026-10-30)

What insurance policy changes affect code M19.041?

Which payers have updated policy for code M19.041?

How do I get notified when code M19.041 policy changes?

Why do payers change policies for code M19.041?